glp 1 receptor brain GLP-1 agonists show promise in treating substance use disorders Brain GLP‐1 and the regulation

That said, a 2023 review suggests tirzepatide may be more effective than semaglutide for people with PCOS thanks to a few key reasons: Great weight loss: The reviews authors cite that tirzepatide has demonstrated more significant weight loss than semaglutide in multiple clinical trials

Tracking your progress and adjusting your approach Managing GLP-1 constipation is not a one-size-fits-all proposition

GLP-1 is released in your gut after you eat, acting as a messenger between your digestive system and your brain

10.1016/j.diabet.2021.101223 94 SongG.YangD.WangY.de GraafC.ZhouQ.JiangS.et al (2017)

10.1038/s41574-022-00783-3 31 HavranekB.LohR.TorreB.RedfieldR.Halegoua-DemarzioD

Patients who switched from tirzepatide to orforglipron maintained a mean 74.7% of their body weight reduction from the SURMOUNT-5 trial compared with those in the placebo group, which maintained a mean 49.2% of their weight loss